Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
about
Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophyAntisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.Genome engineering: a new approach to gene therapy for neuromuscular disorders.Muscle dysfunction caused by loss of Magel2 in a mouse model of Prader-Willi and Schaaf-Yang syndromes.Facioscapulohumeral Muscular Dystrophy.
P2860
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@en
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@nl
type
label
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@en
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@nl
prefLabel
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@en
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@nl
P2093
P2860
P356
P1433
P1476
Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.
@en
P2093
Sachchida Nand Pandey
Toshifumi Yokota
Yi-Chien Lee
Yi-Wen Chen
P2860
P304
P356
10.1038/MT.2013.263
P577
2013-11-14T00:00:00Z